Prevalence of diagnosed and undiagnosed osteoarthrosis and associated factors in the adult general Spanish population.
Artrosis
Diagnosis
Diagnóstico
Dolor
Estado de salud
Health status
Osteoarthrosis
Pain
Prevalence
Prevalencia
Journal
Atencion primaria
ISSN: 1578-1275
Titre abrégé: Aten Primaria
Pays: Spain
ID NLM: 9111075
Informations de publication
Date de publication:
11 Apr 2024
11 Apr 2024
Historique:
received:
18
08
2023
revised:
16
02
2024
accepted:
21
02
2024
medline:
13
4
2024
pubmed:
13
4
2024
entrez:
12
4
2024
Statut:
aheadofprint
Résumé
To determine the prevalence and related factors of diagnosed osteoarthrosis (DO) and undiagnosed osteoarthrosis (UO) in the general Spanish adult population. Cross-sectional study with data from the Spanish National Health Survey 2017. N=23,089 adults. Three groups of people were defined: DO, UO, and no osteoarthrosis (NO). Sociodemographic information, lifestyle (tobacco, alcohol, physical activity, body mass index) and health factors (intensity of pain, pain drug consumption, mental health, self-perceived health status, pain involvement in daily living) were collected. Descriptive and bivariate analyses were performed, and a multinomial logistic regression model for the factors associated with each group. The prevalence of DO was 22.4% (95%CI=21.8;22.9) and 0.9% (95%CI=0.8;1) of UO. With respect to NO, risk factors for DO and UO included higher pain levels and pain drug consumption. Better self-perceived health status was inversely related with both. More pain involvement in daily living was associated with increased risk of DO, but reduced risk of UO. The prevalence of DO and UO was similar to that reported in Europe, but slightly higher than in low/middle-income countries. It was more prevalent in females, older people, people with worse perceived health status and worse mental health. Higher pain levels and pain drug consumption were risk factors for DO and UO. Better self-perceived health status was protective. Pain involvement in daily living was a risk factor for DO, but protective for UO. Different public health strategies should be considered in view of this.
Identifiants
pubmed: 38608330
pii: S0212-6567(24)00072-6
doi: 10.1016/j.aprim.2024.102930
pmc: PMC11024492
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
102930Informations de copyright
Copyright © 2024. Publicado por Elsevier España S.L.U.
Références
Pain Pract. 2020 Feb;20(2):179-187
pubmed: 31556216
Rheumatol Int. 2021 Jul;41(7):1221-1231
pubmed: 33907879
Ann Rheum Dis. 2020 Jun;79(6):819-828
pubmed: 32398285
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Sci Rep. 2021 Nov 8;11(1):21845
pubmed: 34750468
Reumatol Clin (Engl Ed). 2021 Oct;17(8):461-470
pubmed: 34625149
Rheumatology (Oxford). 2015 May;54(5):827-35
pubmed: 25313145
Am J Clin Nutr. 2016 May;103(5):1197-203
pubmed: 27030535
Autoimmun Rev. 2018 Nov;17(11):1097-1104
pubmed: 30213694
Arthritis Care Res (Hoboken). 2020 Feb;72(2):193-200
pubmed: 31479193
Lancet. 2015 Jul 25;386(9991):376-87
pubmed: 25748615
Int J Rheum Dis. 2011 May;14(2):113-21
pubmed: 21518309
Med Clin North Am. 2020 Mar;104(2):293-311
pubmed: 32035570
Rheumatology (Oxford). 2014 May;53(5):937-47
pubmed: 24489012
Eur J Pain. 2006 May;10(4):287-333
pubmed: 16095934
Age Ageing. 2016 Mar;45(2):228-35
pubmed: 26795974
Psicothema. 2008 Nov;20(4):839-43
pubmed: 18940092